Holen Sie sich die Stockscreener-App
6.73
7.30%
-0.53
Handel nachbörslich:
6.71
-0.02
-0.30%
Schlusskurs vom Vortag:
$7.26
Offen:
$7.4
24-Stunden-Volumen:
1.45M
Relative Volume:
2.02
Marktkapitalisierung:
$158.76M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-52.07M
KGV:
-32.40
EPS:
-0.2077
Netto-Cashflow:
$-44.93M
1W Leistung:
+3.38%
1M Leistung:
+10.69%
6M Leistung:
+3.54%
1J Leistung:
-32.63%
1-Tages-Spanne:
$6.48
$7.4375
1-Wochen-Bereich:
$6.48
$8.00
52-Wochen-Spanne:
$4.81
$13.88
Cybin Inc Stock (CYBN) Company Profile
Firmenname
Cybin Inc
Sektor
Branche
Telefon
908 764 8385
Adresse
100 King Street West, Suite 5600, Toronto
Vergleichen Sie CYBN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CYBN
Cybin Inc
|
6.73 | 200.49M | 0 | -52.07M | -44.93M | -0.2077 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Cybin Inc Stock (CYBN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-13 | Eingeleitet | Guggenheim | Buy |
| 2021-11-19 | Herabstufung | Maxim Group | Buy → Hold |
Cybin Inc Aktie (CYBN) Neueste Nachrichten
Cybin Chief Medical Officer to Present at 2025 Milken Institute Health Summit - citybuzz -
Live market analysis of Cybin Inc.Earnings Beat & Accurate Entry and Exit Point Alerts - newser.com
Can technical indicators confirm Cybin Inc.’s reversalQuarterly Earnings Report & Consistent Profit Focused Trading Strategies - newser.com
Long term hold vs stop loss in Cybin Inc.Portfolio Return Summary & Safe Entry Zone Identification - newser.com
Custom strategy builders for tracking Cybin Inc.July 2025 Spike Watch & Long-Term Investment Growth Plans - newser.com
Cybin to Participate at the 2025 Milken Institute Future of Health Summit - The Joplin Globe
Is Cybin Inc. stock ready for a breakoutRisk Management & Consistent Profit Alerts - newser.com
What market sentiment indicators show for Cybin Inc. Common Shares stock2025 Macro Impact & Real-Time Volume Analysis - newser.com
Can Cybin Inc. Common Shares stock surprise markets with earningsQuarterly Trade Review & Risk Controlled Daily Plans - newser.com
Will Cybin Inc. stock benefit from sector rotation2025 Technical Patterns & Risk Controlled Swing Alerts - newser.com
Price momentum metrics for Cybin Inc. explained2025 Key Lessons & Safe Investment Capital Preservation Plans - newser.com
Is Cybin Inc. stock cheap at current valuationJuly 2025 Summary & Low Drawdown Trading Strategies - newser.com
Can Cybin Inc. stock deliver surprise earnings beatJuly 2025 Setups & Weekly Watchlist for Hot Stocks - newser.com
How Cybin Inc. stock compares to growth peersJuly 2025 Chart Watch & Fast Entry High Yield Stock Tips - newser.com
Using Python tools to backtest Cybin Inc. strategiesSwing Trade & Real-Time Volume Trigger Notifications - newser.com
What hedge fund activity signals for Cybin Inc. stock2025 Key Lessons & Free Reliable Trade Execution Plans - newser.com
Is Cybin Inc. stock oversold or undervaluedJuly 2025 Decliners & Real-Time Market Sentiment Alerts - newser.com
Will Cybin Inc. (R7E) stock profit from automation waveWeekly Investment Report & Community Verified Swing Trade Signals - newser.com
Cybin Inc. (NYSEAMERICAN:CYBN) Short Interest Update - MarketBeat
Will Cybin Inc. stock gain from strong economyDip Buying & Free Fast Entry Momentum Trade Alerts - newser.com
Why Cybin Inc. Common Shares stock is a strong analyst pickJuly 2025 Update & Fast Gain Stock Trading Tips - newser.com
Is Cybin Inc. (R7E) stock a fit for income portfoliosRate Cut & AI Optimized Trading Strategy Guides - newser.com
Cybin raises $175 million in direct offering to fund clinical programs - Investing.com Australia
Cybin raises $175 million in direct offering to fund clinical programs By Investing.com - Investing.com South Africa
[6-K] CYBIN INC. Current Report (Foreign Issuer) | CYBN SEC FilingForm 6-K - Stock Titan
Cybin Closes $175 Million Direct Offering - MarketScreener
Cybin Announces Closing of $175 Million Registered Direct Offering - The Joplin Globe
Finanzdaten der Cybin Inc-Aktie (CYBN)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.64%
0.35%
Kapitalisierung:
|
Volumen (24h):